Alteogen Co. posted a 900% jump in Q3 revenue, driven by the commercialization of its ALT-B4 platform and milestone payments from FDA-approved Keytruda SC, marking a major turnaround in profitability and global expansion momentum.
#YonhapInfomax #Alteogen #ALTB4 #Q3Revenue #Keytruda #FDAApproval #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=90913
#keytruda
🌿 Toàn cảnh Keytruda – Thuốc ung thư bán chạy nh ất thế giới
🌿 Toàn cảnh Keytruda – Thuốc ung thư bán chạy nhất thế giới 💖👉🍀🍀🤔 #ungthu #Keytruda #miendich #Merck #biosimilar #suckhoe 1️⃣ Vị thế số một của Keytruda trên thị trường toàn cầu Trong vòng một thập niên, Keytruda (Pembrolizumab) của Merck đã tạo nên kỷ lục hiếm có: doanh thu vượt 146 tỷ USD, trở thành thuốc ung thư bán chạy nhất thế giới.
🌿 Toàn cảnh Keytruda – Thuốc ung thư bán chạy nh ất thế giới
🌿 Toàn cảnh Keytruda – Thuốc ung thư bán chạy nhất thế giới 💖👉🍀🍀🤔 #ungthu #Keytruda #miendich #Merck #biosimilar #suckhoe 1️⃣ Vị thế số một của Keytruda trên thị trường toàn cầu Trong vòng một thập niên, Keytruda (Pembrolizumab) của Merck đã tạo nên kỷ lục hiếm có: doanh thu vượt 146 tỷ USD, trở thành thuốc ung thư bán chạy nhất thế giới.
Merus shares hit record highs after Phase 2 data showed strong survival rates for its head and neck cancer therapy, fueling Wall Street optimism and positive analyst outlooks.
#YonhapInfomax #Merus #Keytruda #Phase2Data #SurvivalRate #SharePrice #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=66099
GI Innovation is set to sign South Korea’s first immuno-oncology technology licensing deal with Merck, potentially marking a milestone for the domestic biotech sector as talks near completion for GI-101 and GI-102 combination with Keytruda.
#YonhapInfomax #GIInnovation #Merck #ImmunoOncology #Keytruda #TechnologyTransfer #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=65767
https://www.alojapan.com/1286046/merck-replaces-china-chief-with-japan-head-to-revive-growth/ Merck Replaces China Chief With Japan Head to Revive Growth #AnnaVanAcker #Gardasil #hpv #Japan #JapanNews #JapanTopics #Keytruda #KyleTattle #Merck #MSD #MSDChina #news #oncology #pharma (Yicai) May 30 — US drugmaker Merck is replacing the head of its China operations with Kyle Tattle, the current president of the company’s Japan division, following a steep decline in first-quarter revenue. Tattle will assume leadership after Anna Van Acker, …
B.C. woman fighting cancer denied immunotherapy drug due to trial period
Soledad Ronco struggled through chemotherapy while also receiving the immunotherapy drug Keytruda to keep the triple-negative breast cancer at bay.
#globalnews #Health #BCCancerAgency #Immunotherapy #Keytruda
https://globalnews.ca/news/10689293/bc-woman-cancer-denied-immunotherapy-drug/
B.C. woman fighting cancer denied immunotherapy drug due to trial period
Soledad Ronco struggled through chemotherapy while also receiving the immunotherapy drug Keytruda to keep the triple-negative breast cancer at bay.
#globalnews #Health #BCCancerAgency #Immunotherapy #Keytruda
https://globalnews.ca/news/10689293/bc-woman-cancer-denied-immunotherapy-drug/
B.C. woman fighting cancer denied immunotherapy drug due to trial period
Soledad Ronco struggled through chemotherapy while also receiving the immunotherapy drug Keytruda to keep the triple-negative breast cancer at bay.
#globalnews #Health #BCCancerAgency #Immunotherapy #Keytruda
https://globalnews.ca/news/10689293/bc-woman-cancer-denied-immunotherapy-drug/
Keytruda strikes out again in endometrial cancer with phase III flop—Novo inks $600M deal with Metaphore to develop next-gen obesity drugs —Takeda Pharma to restructure after annual profit slump --http://bit.ly/w28kSd #merck #keytruda #endometrialcancer #clinicaltrials #novonordisk #obesity #drugdevelopment #takeda #restructuring #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Galderma sets IPO price at top of range—Merck combination treatment for lung cancer fails late-stage study—With executive shakeup and new pharma unit, Bayer's overhaul takes shape--http://bit.ly/w28kSd #ipos #galderma #merck #lungcancer #keytruda #clinicaltrials #bayer #restructuring #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Pembrolizumab, sold under the brand name #Keytruda, targets and blocks a specific protein on the surface of certain immune cells that then seek out and destroy the cancerous cells.
In England it is offered to those with #triple-#negative #breast #cancer, one of the most aggressive forms of the disease, which accounts for about 15% of cases.
However, new findings from a global trial suggest it could be effective when used more widely
Merck’s Keytruda pushes towards earlier stages of cervical cancer with phase III data—Gilead CAR-T cancer therapy capacity to quadruple by 2026—Madrigal wins FDA approval of first drug for MASH--http://bit.ly/w28kSd #merck #keytruda #cervicalcancer #clinicaltrials #cart #gileadsciences #fda #mash #nash #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
AstraZeneca boosts rare disease portfolio with $1.05B Amolyt acquisition—Merck takes Keytruda patent dispute with Johns Hopkins University from the court to the patent office—A simple blood test can detect colorectal cancer early, study finds--http://bit.ly/w28kSd #mergersandacquisitions #astrazeneca #raredisease #merck #patents #johnshopkins #keytruda #colorectalcancer #medtech #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Moderna posts surprise quarterly profit as it eyes RSV vaccine approval —Samsung joins biosimilar race for Merck & Co.'s Keytruda blockbuster—Zimmer receives FDA clearance for robotic shoulder system--http://bit.ly/w28kSd #moderna #rsv #vaccines #merck #samsung #biosimilars #keytruda #roboticsurgery #zimmerbiomet #fda #shoulderreplacement #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
In Medicare negotiation process, HHS sends 1st price offers—Sanofi Q4 earnings hit by weak dollar, generic competition — Merck seeks more deals to prepare for Keytruda's revenue decline--http://bit.ly/w28kSd #medicare #hhs #drugpricing #sanofi #merck #keytruda #earnings #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
After Padcev combo’s major triumph, Merck’s Keytruda delivers partial win in bladder cancer —ArriVent takes in $175M from second biotech IPO of the year — No decision yet on Wegovy heart benefits from EU drug regulator--http://bit.ly/w28kSd #merck #bladdercancer #keytruda #ipo #wegovy #europe #novonordisk #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Powerful New Skin Cancer Therapy Cuts Risk of Death by Half
https://www.sciencealert.com/powerful-new-skin-cancer-therapy-cuts-risk-of-death-by-half #SkinCancer #Therapy Cuts #Risk #Death #Half #KEYTRUDA #vaccine #mRNA #moderna
"#Moderna hofft auf #Hautkrebs-Impfstoff ab 2025
Der US-Pharmakonzern Moderna hofft, 2025 einen Impfstoff gegen schwarzen Hautkrebs auf den Markt bringen zu können. Neue Ergebnisse einer klinischen #Studie sind vielversprechend."
#Immuntherapie #Onkologie #Antikörpermedikament #Keytruda
https://www.zdf.de/nachrichten/wirtschaft/moderna-impfstoff-schwarzer-hautkrebs-100.html
For Merck, Lynparza fails to improve on Keytruda in first-line lung cancer-- AbbVie to buy Cerevel in $8.7B bet on brain drugs --Trial finds Lilly’s Olumiant could treat type 1 diabetes --http://bit.ly/w28kSd #merck #keytruda #lungcancer #mergersandacquisitions #elililly #clinicaltrials #type1diabetes #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Client Info
Server: https://mastodon.social
Version: 2025.07
Repository: https://github.com/cyevgeniy/lmst